Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
04/11/2025 | PUT | $89.00 | 3,331 | +3,209 | +2,630.33% |
04/04/2025 | CALL | $89.00 | 1,393 | +1,297 | +1,351.04% |
04/25/2025 | CALL | $95.00 | 952 | +825 | +649.61% |
04/04/2025 | PUT | $89.00 | 1,831 | +667 | +57.30% |
04/04/2025 | CALL | $90.00 | 6,958 | +574 | +8.99% |
09/19/2025 | CALL | $90.00 | 1,552 | +537 | +52.91% |
01/16/2026 | CALL | $80.00 | 862 | -75 | -8.00% |
04/17/2025 | CALL | $115.00 | 2,323 | -84 | -3.49% |
04/11/2025 | PUT | $85.00 | 1,181 | -92 | -7.23% |
06/20/2025 | CALL | $65.00 | 115 | -114 | -49.78% |
04/17/2025 | CALL | $89.00 | 1,342 | -165 | -10.95% |
04/17/2025 | PUT | $86.00 | 2,985 | -275 | -8.44% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 3.04% | 77.07M | 8.28B |
Vanguard 500 Index Fund | 2.31% | 58.61M | 6.3B |
Fidelity 500 Index Fund | 1.09% | 27.79M | 2.99B |
SPDR S&P 500 ETF Trust | 1.08% | 27.45M | 2.95B |
iShares Core S&P 500 ETF | 0.89% | 22.63M | 2.43B |
Vanguard Index-Value Index Fund | 0.86% | 21.91M | 2.35B |
Select Sector SPDR Fund-Health Care | 0.81% | 20.59M | 2.21B |
Vanguard Specialized-Health Care Fund | 0.72% | 18.31M | 1.97B |
Vanguard Institutional Index Fund-Institutional Index Fund | 0.70% | 17.77M | 1.91B |
Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF | 0.68% | 17.38M | 1.87B |
Deadline Alert: Merck & Co (MRK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
03/31 12:00 pm
GlobeNewswire Inc.
Read moreWhy Pfizer Is My Largest Healthcare Position
03/27 06:45 am
The Motley Fool
Read moreWhy Summit Therapeutics Stock Slipped Today
03/26 05:21 pm
The Motley Fool
Read moreDEADLINE ALERT for ICLR, ESTC, FMC, MRK: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
03/26 12:00 pm
GlobeNewswire Inc.
Read moreWhy Pharma and Biotech Stocks Got Thrashed on Tuesday
03/25 06:47 pm
The Motley Fool
Read moreAnalyst Initiates Coverage On 'Undervalued' Summit Therapeutics
03/24 02:17 pm
Benzinga
Read morePharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
03/21 12:31 pm
Benzinga
Read moreThe Gross Law Firm Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 – MRK
03/20 01:01 pm
GlobeNewswire Inc.
Read moreDeadline Alert: Merck & Co (MRK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
03/18 12:00 pm
GlobeNewswire Inc.
Read moreROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
03/16 05:57 am
GlobeNewswire Inc.
Read moreShould You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
03/16 05:20 am
The Motley Fool
Read moreDown 93%, Is It Finally Time to Buy Moderna?
03/15 04:38 am
The Motley Fool
Read moreROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
03/13 06:59 pm
GlobeNewswire Inc.
Read moreBioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - Report by Transparency Market Research, Inc.
03/13 06:00 pm
GlobeNewswire Inc.
Read moreThis Could Be the Catalyst That Sends Summit Therapeutics' Stock Higher This Year
03/13 07:30 am
The Motley Fool
Read moreMerck Plans Regulatory Submission For Two-Drug Regime For HIV Infection By Mid-2025
03/12 01:30 pm
Benzinga
Read moreROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
03/10 06:23 pm
GlobeNewswire Inc.
Read more3 Magnificent S&P 500 Dividend Stocks Down 20% to 63% to Buy and Hold Forever
03/09 04:35 am
The Motley Fool
Read moreIs This Beaten-Down Artificial Intelligence (AI) Stock a Buy?
03/08 11:02 am
The Motley Fool
Read more5 Top Stocks to Buy for March
03/08 10:54 am
The Motley Fool
Read more3 Safe-Haven Stocks to Buy Amidst a Global Trade War
03/05 10:35 am
Investing.com
Read moreROSEN, A LEADING NATIONAL FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
03/04 08:57 pm
GlobeNewswire Inc.
Read moreDEADLINE ALERT for ICLR, ESTC, FMC, MRK: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
03/04 01:00 pm
GlobeNewswire Inc.
Read moreROSEN, A LEADING LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
03/01 02:14 pm
GlobeNewswire Inc.
Read moreMerck & Co., Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; April 14, 2025 Deadline to file Lead Plaintiff Motion
02/27 04:53 pm
GlobeNewswire Inc.
Read moreGlobal Human Liver Model Market 2025-2030: Growth Driven by 3D Bioprinting & Liver Disease Research
02/27 11:54 am
GlobeNewswire Inc.
Read moreCan Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?
02/27 11:05 am
The Motley Fool
Read moreROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
02/26 08:00 pm
GlobeNewswire Inc.
Read moreDEADLINE ALERT for ICLR, ESTC, FMC, MRK: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
02/26 01:00 pm
GlobeNewswire Inc.
Read moreLAG-3 Immunotherapies Market Set for Rapid Growth in the Coming 10 Years Across the 7MM as Next-Generation Therapies Advance | DelveInsight
02/25 02:00 pm
GlobeNewswire Inc.
Read moreEvaxion extends phase 2 trial with personalized cancer vaccine EVX-01 to further enhance clinical data package
02/25 09:00 am
GlobeNewswire Inc.
Read moreQuestex’s Fierce Pharma Unveils the Conference Program for the Inaugural Fierce Pharma Engage, Over 100 Speakers Confirmed to Deliver Unparalleled Education
02/24 11:00 am
GlobeNewswire Inc.
Read more3 Magnificent S&P 500 Dividend Stocks Down 36% to 64% to Buy and Hold Forever
02/24 08:00 am
The Motley Fool
Read moreROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
02/23 11:54 pm
GlobeNewswire Inc.
Read moreMERCK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MRK
02/22 06:15 pm
GlobeNewswire Inc.
Read moreHyperlipidemia Drugs Market Size to Promote USD 31.49 Bn by 2034
02/21 11:00 am
GlobeNewswire Inc.
Read moreROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
02/20 05:50 pm
GlobeNewswire Inc.
Read moreBESREMi Achieves Strong Market Growth Amid Rising Demand for Polycythemia Vera Treatment
02/20 02:00 pm
GlobeNewswire Inc.
Read moreAntibody-Drug Conjugates Market to Witness Rapid Growth Across 7MM During the Study Period (2020–2034) as New Innovations Drive Therapy Advancements | DelveInsight
02/20 02:00 pm
GlobeNewswire Inc.
Read moreNorth America Leads the Beta-Glucan Boom: Market Insights & Industry Innovations
02/19 09:45 pm
GlobeNewswire Inc.
Read moreMERCK & CO., INC. (NYSE: MRK) INVESTOR ALERT: Investors With Large Losses in Merck & Co., Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
02/19 02:50 pm
GlobeNewswire Inc.
Read moreGlobal Immune Checkpoint Inhibitors Market to Cross USD 100 Billion by 2032 | DelveInsight
02/18 02:00 pm
GlobeNewswire Inc.
Read more3 Blue-Chip Dividend Stocks Trading at Multiyear Lows
02/13 10:30 am
The Motley Fool
Read moreRespiratory Syncytial Virus Therapeutics Market to Hit USD 4.64 Billion by 2032, Growing at a 14.5% CAGR – SNS Insider
02/13 10:00 am
GlobeNewswire Inc.
Read moreWant Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
02/13 07:35 am
The Motley Fool
Read moreMRK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead the Merck Class Action Lawsuit
02/12 07:31 pm
GlobeNewswire Inc.
Read more